Viral pneumonias do not typically respond to antibiotic treatment. These pneumonias usually resolve over time with the body's immune system fighting off the infection. It is important to make sure that a bacterial pneumonia does not secondarily develop. If it does, then the bacterial pneumonia is...
Remdesivir is found to be the most promising antiviral agent among different potential agents tested for the treatment of the disease COVID-19. At first, Remdesivir was developed for the treatment of hepatitis C, and was subsequently repurposed as a therapeutic agent against Ebola and Marburg viru...
Therefore, Chinese medicine treatment has positive impact on infectious lung diseases, as well as the development of new medicines. Conclusion Traditional Chinese medicine has a systemic theoretical understanding on the pathological evolution of novel coronavirus pneumonia and plays a positive role in NCP...
2. 2019新型冠状病毒 2019 novel coronavirus (2019-nCoV) 3.2019新型冠状病毒肺炎 COVID-19 (Corona Virus Disease 2019) 4. 病毒性肺炎 viral pneumonia 5. 不明原因肺炎 pneumonia of unknown etiology/cause 6. 严重急性呼吸综合征(非典) severe acute respiratory syndrome (SARS) 7. 严重急性呼吸道感染 seve...
The two sides agreed to keep in close contact on information sharing and cooperation on technical matters.The NHC and related health departments in Hubei Province produced Treatment Manual for Viral Pneumonia of Unknown Cause. (7)1月5日,武汉市卫生健康委在官方网站发布《关于不明原因的病毒性肺炎情况...
2.Lechowicz,K,Dro˙zd˙zal,S,Machaj,F,Rosik,J,Szostak,B,Zegan-Bara ´nska,M,Biernawska,J,Dabrowski,W,Rotter,I,Kotfifis,K.COVID-19:The potential treatment of pulmonary fifibrosis associated with SARS-CoV-2 infection.JCM 2020,9,19...
The severe acute respiratory syndrome coronavirus (SARS‑CoV)‑2 pandemic has presented unprecedented challenges globally.[1] The viral infection presents with a constellation of symptoms varying from a mild flu‑like illness t...
of the virus is not fully understood, but the pathological picture in the lungs varies significantly in terms of diffuse alveolar damage and microcirculopathy leading to life-threatening hypoxia . Ozone hasmultiple beneficial properties that could be useful in treatmentof COVID-19 pneumonia. ...
Part of the COVID-19 illness is viral lung infection (viral pneumonia). A small number of viral pneumonias can also develop a bacterial infection within the lung. The addition of the bacterial infection on top of the viral infection is called a secondary bacterial infection. ...
Coronavirus disease 2019 (COVID-19) has killed over 2.5 million people worldwide, but effective care and therapy have yet to be discovered. We conducted this analysis to better understand tocilizumab treatment for COVID-19 patients. We searched major dat